Silicon Biosystems, Inc., announced today its entry with Fox Chase Cancer Center in Philadelphia, PA into an agreement for the company's DEPArray™ technology. Dr. Massimo Cristofanilli, Professor and Chairman of the Department of Medical Oncology, and his colleagues at Fox Chase Cancer Center will use DEPArray™ technology to advance understanding of micrometastatic disease and the genetic heterogeneity of cancers.

---